{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T20:46:07Z","timestamp":1779309967640,"version":"3.51.4"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Nephrol"],"published-print":{"date-parts":[[2006,5,1]]},"DOI":"10.1038\/ncpneph0166","type":"journal-article","created":{"date-parts":[[2006,5,16]],"date-time":"2006-05-16T16:47:31Z","timestamp":1147798051000},"page":"254-262","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":78,"title":["Viral nephropathy"],"prefix":"10.1038","volume":"2","author":[{"given":"Andrew SH","family":"Lai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kar Neng","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"issue":"Suppl 35","key":"BFncpneph0166_CR1","first-page":"S5","volume":"40","author":"RJ Glassock","year":"1991","unstructured":"Glassock RJ (1991) Immune complex-induced glomerular injury in viral diseases: an overview. Kidney Int 40 (Suppl 35): S5\u2013S7","journal-title":"Kidney Int"},{"key":"BFncpneph0166_CR2","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/ki.1985.167","volume":"28","author":"WG Couser","year":"1985","unstructured":"Couser WG (1985) Mechanisms of glomerular injury in immune-complex disease. Kidney Int 28: 569\u2013583","journal-title":"Kidney Int"},{"key":"BFncpneph0166_CR3","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/ki.1979.116","volume":"16","author":"SM Golbus","year":"1979","unstructured":"Golbus SM and Wilson C (1979) Experimental glomerulonephritis induced by in-situ formation of immune complexes in glomerular capillary wall. Kidney Int 16: 148\u2013157","journal-title":"Kidney Int"},{"key":"BFncpneph0166_CR4","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1172\/JCI3480","volume":"102","author":"PG Conaldi","year":"1998","unstructured":"Conaldi PG  et al. (1998) HIV-1 kills renal tubular epithelial cells in vitro by triggering an apoptotic pathway involving caspase activation and Fas upregulation. J Clin Invest 102: 2041\u20132049","journal-title":"J Clin Invest"},{"key":"BFncpneph0166_CR5","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1681\/ASN.V111152","volume":"11","author":"S Segerer","year":"2000","unstructured":"Segerer S  et al. (2000) Chemokines, chemokine receptors, and renal disease: from basic science to pathophysiologic and therapeutic studies. J Am Soc Nephrol 11: 152\u2013176","journal-title":"J Am Soc Nephrol"},{"key":"BFncpneph0166_CR6","doi-asserted-by":"publisher","first-page":"35","DOI":"10.7326\/0003-4819-112-1-35","volume":"112","author":"RJ Glassock","year":"1990","unstructured":"Glassock RJ  et al. (1990) Human immunodeficiency virus infection and the kidney. Ann Intern Med 112: 35\u201339","journal-title":"Ann Intern Med"},{"key":"BFncpneph0166_CR7","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1046\/j.1523-1755.1998.00028.x","volume":"54","author":"G D'Amico","year":"1998","unstructured":"D'Amico G (1998) Renal involvement in hepatitis C infection: cryoglobulinemic glomerulonephritis. Kidney Int 54: 650\u2013671","journal-title":"Kidney Int"},{"key":"BFncpneph0166_CR8","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1046\/j.1523-1755.2001.00727.x","volume":"59","author":"A Moudgil","year":"2001","unstructured":"Moudgil A  et al. (2001) Association of parvovirus B19 infection with idiopathic collapsing glomerulopathy. Kidney Int 59: 2126\u20132133","journal-title":"Kidney Int"},{"key":"BFncpneph0166_CR9","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1016\/S0272-6386(00)70055-2","volume":"35","author":"S Tanawattanacharoen","year":"2000","unstructured":"Tanawattanacharoen S  et al. (2000) Parvovirus B19 DNA in kidney tissue of patients with focal segmental glomerulosclerosis. Am J Kidney Dis 35: 1166\u20131174","journal-title":"Am J Kidney Dis"},{"key":"BFncpneph0166_CR10","doi-asserted-by":"publisher","first-page":"E31","DOI":"10.1016\/S0272-6386(00)70070-9","volume":"35","author":"T Nakazawa","year":"2000","unstructured":"Nakazawa T  et al. (2000) Acute glomerulonephritis after human parvovirus B19 infection. Am J Kidney Dis 35: E31","journal-title":"Am J Kidney Dis"},{"key":"BFncpneph0166_CR11","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1093\/clinids\/9.1.165","volume":"9","author":"TP Monath","year":"1987","unstructured":"Monath TP (1987) Yellow fever: a medically neglected disease: report on a seminar. Rev Infect Dis 9: 165\u2013175","journal-title":"Rev Infect Dis"},{"key":"BFncpneph0166_CR12","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1536\/ihj.30.109","volume":"30","author":"S Ozkutlu","year":"1989","unstructured":"Ozkutlu S  et al. (1989) Fatal mumps myocarditis. Jpn Heart J 30: 109\u2013114","journal-title":"Jpn Heart J"},{"key":"BFncpneph0166_CR13","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1542\/peds.71.3.398","volume":"71","author":"CY Lin","year":"1983","unstructured":"Lin CY and Hsu HC (1983) Measles and acute glomerulonephritis. Pediatrics 71: 398\u2013401","journal-title":"Pediatrics"},{"issue":"Suppl 35","key":"BFncpneph0166_CR14","first-page":"S2","volume":"40","author":"SI Vas","year":"1991","unstructured":"Vas SI (1991) Primary and secondary role of viruses in chronic renal failure. Kidney Int 40 (Suppl 35): S2\u2013S4","journal-title":"Kidney Int"},{"key":"BFncpneph0166_CR15","first-page":"173","volume":"89","author":"T Toth","year":"1988","unstructured":"Toth T and Szucs S (1988) Focal-segmental glomerulosclerosis associated with herpes simplex viral encephalitis. Child Nephrol Urol 89: 173\u2013175","journal-title":"Child Nephrol Urol"},{"issue":"Suppl 35","key":"BFncpneph0166_CR16","first-page":"S24","volume":"40","author":"M Levy","year":"1991","unstructured":"Levy M and Chen N (1991) Worldwide perspective of hepatitis B-associated glomerulonephritis in the 80s. Kidney Int 40 (Suppl 35): S24\u2013S33","journal-title":"Kidney Int"},{"issue":"Suppl 35","key":"BFncpneph0166_CR17","first-page":"S40","volume":"40","author":"KN Lai","year":"1991","unstructured":"Lai KN and Lai FM (1991) Clinical features and the natural course of hepatitis B virus-related glomerulopathy in adults. Kidney Int 40 (Suppl 35): S40\u2013S45","journal-title":"Kidney Int"},{"issue":"Suppl 35","key":"BFncpneph0166_CR18","first-page":"S46","volume":"40","author":"CY Lin","year":"1991","unstructured":"Lin CY (1991) Clinical features and natural course of HBV-related glomerulopathy in children. Kidney Int 40 (Suppl 35): S46\u2013S53","journal-title":"Kidney Int"},{"key":"BFncpneph0166_CR19","first-page":"229","volume":"29","author":"KN Lai","year":"1988","unstructured":"Lai KN  et al. (1988) Strong association between IgA nephropathy and hepatitis B surface antigenemia in endemic areas. Clin Nephrol 29: 229\u2013234","journal-title":"Clin Nephrol"},{"key":"BFncpneph0166_CR20","first-page":"143","volume":"141","author":"DN Peters","year":"1992","unstructured":"Peters DN  et al. (1992) Immunopathology of glomerulonephritis associated with chronic woodchuck hepatitis virus infection in woodchucks. Am J Pathol 141: 143\u2013152","journal-title":"Am J Pathol"},{"key":"BFncpneph0166_CR21","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1056\/NEJM199105233242103","volume":"324","author":"KN Lai","year":"1991","unstructured":"Lai KN  et al. (1991) Membranous nephropathy related to hepatitis B virus in adults. N Engl J Med 324: 1457\u20131463","journal-title":"N Engl J Med"},{"key":"BFncpneph0166_CR22","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1128\/JCM.37.8.2461-2465.1999","volume":"37","author":"SK Ho","year":"1999","unstructured":"Ho SK  et al. (1999) Comparison of the second-generation digene hybrid capture assay with the branched-DNA assay for measurement of hepatitis B virus DNA in serum. J Clin Microbiol 37: 2461\u20132465","journal-title":"J Clin Microbiol"},{"key":"BFncpneph0166_CR23","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1002\/(SICI)1096-9098(199910)72:2<99::AID-JSO11>3.0.CO;2-1","volume":"72","author":"S Tang","year":"1999","unstructured":"Tang S  et al. (1999) Early detection of hepatocellular carcinoma in hepatitis-B-positive renal transplant recipients. J Surg Oncol 72: 99\u2013101","journal-title":"J Surg Oncol"},{"key":"BFncpneph0166_CR24","first-page":"377","volume-title":"Rheumatology and the Kidney","author":"KN Lai","year":"2001","unstructured":"Lai KN (2001) Hepatitis B associated renal disease. In: Rheumatology and the Kidney, 377\u2013396 (Eds Adu D  et al.) Oxford: Oxford University Press"},{"key":"BFncpneph0166_CR25","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1111\/j.1523-1755.2005.00591.x","volume":"68","author":"S Tang","year":"2005","unstructured":"Tang S  et al. (2005) Lamivudine in hepatitis B-associated membranous nephropathy. Kidney Int 68: 1750\u20131758","journal-title":"Kidney Int"},{"key":"BFncpneph0166_CR26","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/0016-5085(95)90343-7","volume":"109","author":"HS Conjeevaram","year":"1995","unstructured":"Conjeevaram HS  et al. (1995) Long-term outcome of hepatitis B virus-related glomerulonephritis after therapy with interferon alfa. Gastroenterology 109: 540\u2013546","journal-title":"Gastroenterology"},{"key":"BFncpneph0166_CR27","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1097\/00000478-199402000-00007","volume":"18","author":"FM Lai","year":"1994","unstructured":"Lai FM  et al. (1994) Primary glomerulonephritis with detectable glomerular hepatitis B virus antigens. Am J Surg Pathol 18: 175\u2013186","journal-title":"Am J Surg Pathol"},{"key":"BFncpneph0166_CR28","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1097\/01.meg.0000108362.41221.57","volume":"16","author":"HL Janssen","year":"2004","unstructured":"Janssen HL  et al. (2004) Polyarteritis nodosa associated with hepatitis B virus infection: the role of antiviral treatment and mutations in the hepatitis B virus genome. Eur J Gastroenterol Hepatol 16: 801\u2013807","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"BFncpneph0166_CR29","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/S0272-6386(99)70374-4","volume":"34","author":"S Tang","year":"1999","unstructured":"Tang S  et al. (1999) Skin lesions, hepatitis, and nephropathy in a 30-year-old man. Am J Kidney Dis 34: 380\u2013383","journal-title":"Am J Kidney Dis"},{"key":"BFncpneph0166_CR30","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s00467-002-0978-z","volume":"18","author":"SO Ozdamar","year":"2003","unstructured":"Ozdamar SO  et al. (2003) Hepatitis-B virus associated nephropathies: a clinicopathological study in 14 children. Pediatr Nephrol 18: 23\u201328","journal-title":"Pediatr Nephrol"},{"key":"BFncpneph0166_CR31","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1159\/000185802","volume":"54","author":"KN Lai","year":"1990","unstructured":"Lai KN  et al. (1990) The therapeutic dilemma of the usage of corticosteroid in patients with membranous nephropathy and persistent hepatitis B virus surface antigenaemia. Nephron 54: 12\u201317","journal-title":"Nephron"},{"key":"BFncpneph0166_CR32","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/ki.1995.27","volume":"47","author":"CY Lin","year":"1995","unstructured":"Lin CY (1995) Treatment of hepatitis B virus-associated membranous nephropathy with recombinant alpha-interferon. Kidney Int 47: 225\u2013230","journal-title":"Kidney Int"},{"key":"BFncpneph0166_CR33","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1056\/NEJM199807093390201","volume":"339","author":"CL Lai","year":"1998","unstructured":"Lai CL  et al. (1998) A one-year trial of lamivudine for chronic hepatitis B: Asia Hepatitis Lamivudine Study Group. N Engl J Med 339: 61\u201368","journal-title":"N Engl J Med"},{"key":"BFncpneph0166_CR34","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1136\/adc.88.5.446","volume":"88","author":"FL Connor","year":"2003","unstructured":"Connor FL  et al. (2003) HBV associated nephrotic syndrome: resolution with oral lamivudine. Arch Dis Child 88: 446\u2013449","journal-title":"Arch Dis Child"},{"key":"BFncpneph0166_CR35","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1053\/jhep.2000.8626","volume":"32","author":"R Perrillo","year":"2000","unstructured":"Perrillo R  et al. (2000) Adefovir dipivoxil for the treatment of lamivudine-resistant hepatitis B mutants. Hepatology 32: 129\u2013134","journal-title":"Hepatology"},{"key":"BFncpneph0166_CR36","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1517\/14656566.5.11.2361","volume":"5","author":"MF Yuen","year":"2004","unstructured":"Yuen MF and Lai CL (2004) Adefovir dipivoxil in chronic hepatitis B infection. Expert Opin Pharmacother 5: 2361\u20132367","journal-title":"Expert Opin Pharmacother"},{"key":"BFncpneph0166_CR37","doi-asserted-by":"publisher","first-page":"2832","DOI":"10.1056\/NEJMcp041507","volume":"351","author":"GA Poland","year":"2004","unstructured":"Poland GA and Jacobson RM (2004) Clinical practice: prevention of hepatitis B with the hepatitis B vaccine. N Engl J Med 351: 2832\u20132838","journal-title":"N Engl J Med"},{"key":"BFncpneph0166_CR38","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1056\/NEJM199706263362602","volume":"336","author":"MH Chang","year":"1997","unstructured":"Chang MH  et al. (1997) Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children: Taiwan Childhood Hepatoma Study Group. N Engl J Med 336: 1855\u20131859","journal-title":"N Engl J Med"},{"key":"BFncpneph0166_CR39","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1517\/14740338.2.3.225","volume":"2","author":"P Duclos","year":"2003","unstructured":"Duclos P (2003) Safety of immunisation and adverse events following vaccination against hepatitis B. Expert Opin Drug Saf 2: 225\u2013231","journal-title":"Expert Opin Drug Saf"},{"key":"BFncpneph0166_CR40","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1056\/NEJM199302183280703","volume":"328","author":"RJ Johnson","year":"1993","unstructured":"Johnson RJ  et al. (1993) Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Engl J Med 328: 465\u2013470","journal-title":"N Engl J Med"},{"key":"BFncpneph0166_CR41","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1002\/hep.1840190407","volume":"19","author":"JM Pawlotsky","year":"1994","unstructured":"Pawlotsky JM  et al. (1994) Immunological disorders in C virus chronic active hepatitis: a prospective case\u2013control study. Hepatology 19: 841\u2013848","journal-title":"Hepatology"},{"key":"BFncpneph0166_CR42","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1053\/jhep.2002.35620","volume":"36","author":"Z Kayali","year":"2002","unstructured":"Kayali Z  et al. (2002) Hepatitis C, cryoglobulinemia, and cirrhosis: a meta-analysis. Hepatology 36: 978\u2013985","journal-title":"Hepatology"},{"key":"BFncpneph0166_CR43","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/ki.1995.82","volume":"47","author":"HG Rennke","year":"1995","unstructured":"Rennke HG (1995) Secondary membranoproliferative glomerulonephritis. Kidney Int 47: 643\u2013656","journal-title":"Kidney Int"},{"key":"BFncpneph0166_CR44","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1093\/ndt\/13.8.1991","volume":"13","author":"F Fabrizi","year":"1998","unstructured":"Fabrizi F  et al. (1998) Hepatitis C virus infection and acute or chronic glomerulonephritis: an epidemiological and clinical appraisal. Nephrol Dial Transplant 13: 1991\u20131997","journal-title":"Nephrol Dial Transplant"},{"key":"BFncpneph0166_CR45","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1046\/j.1523-1755.1998.00028.x","volume":"54","author":"G D'Amico","year":"1998","unstructured":"D'Amico G (1998) Renal involvement in hepatitis C infection: cryoglobulinemic glomerulonephritis. Kidney Int 54: 650\u2013671","journal-title":"Kidney Int"},{"key":"BFncpneph0166_CR46","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1038\/ki.1995.78","volume":"47","author":"A Tarantino","year":"1995","unstructured":"Tarantino A  et al. (1995) Long-term predictors of survival in essential mixed cryoglobulinemic glomerulonephritis. Kidney Int 47: 618\u2013623","journal-title":"Kidney Int"},{"key":"BFncpneph0166_CR47","doi-asserted-by":"publisher","first-page":"144","DOI":"10.5414\/CNP61144","volume":"61","author":"Y Uchiyama-Tanaka","year":"2004","unstructured":"Uchiyama-Tanaka Y  et al. (2004) Membranous glomerulonephritis associated with hepatitis C virus infection: case report and literature review. Clin Nephrol 61: 144\u2013150","journal-title":"Clin Nephrol"},{"key":"BFncpneph0166_CR48","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1016\/S0140-6736(98)07124-4","volume":"352","author":"T Poynard","year":"1998","unstructured":"Poynard T  et al. (1998) Randomised trial of interferon \u03b12b plus ribavirin for 48 weeks or for 24 weeks versus interferon \u03b12b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus: International Hepatitis Interventional Therapy Group (IHIT). Lancet 352: 1426\u20131432","journal-title":"Lancet"},{"key":"BFncpneph0166_CR49","first-page":"2172","volume":"27","author":"E Zuckerman","year":"2000","unstructured":"Zuckerman E  et al. (2000) Treatment of refractory, symptomatic, hepatitis C virus related mixed cryoglobulinemia with ribavirin and interferon-alpha. J Rheumatol 27: 2172\u20132178","journal-title":"J Rheumatol"},{"key":"BFncpneph0166_CR50","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1056\/NEJMoa020047","volume":"347","author":"MW Fried","year":"2002","unstructured":"Fried MW  et al. (2002) Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 347: 975\u2013982","journal-title":"N Engl J Med"},{"key":"BFncpneph0166_CR51","doi-asserted-by":"publisher","first-page":"346","DOI":"10.7326\/0003-4819-140-5-200403020-00010","volume":"140","author":"SJ Hadziyannis","year":"2004","unstructured":"Hadziyannis SJ  et al. PEGASYS International Study Group (2004) Peginterferon-\u03b12a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose. Ann Intern Med 140: 346\u2013355","journal-title":"Ann Intern Med"},{"key":"BFncpneph0166_CR52","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.1046\/j.1523-1755.2003.00022.x","volume":"63","author":"P Rossi","year":"2003","unstructured":"Rossi P  et al. (2003) Hepatitis C virus-related cryoglobulinemic glomerulonephritis: long-term remission after antiviral therapy. Kidney Int 63: 2236\u20132241","journal-title":"Kidney Int"},{"key":"BFncpneph0166_CR53","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1038\/ki.1990.151","volume":"37","author":"JJ Bourgoignie","year":"1990","unstructured":"Bourgoignie JJ (1990) Renal complications of human immunodeficiency virus type 1. Kidney Int 37: 1571\u20131584","journal-title":"Kidney Int"},{"key":"BFncpneph0166_CR54","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1038\/ki.1993.386","volume":"44","author":"PL Kimmel","year":"1993","unstructured":"Kimmel PL  et al. (1993) HIV-associated immune-mediated renal disease. Kidney Int 44: 1327\u20131340","journal-title":"Kidney Int"},{"key":"BFncpneph0166_CR55","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1681\/ASN.V11112079","volume":"11","author":"LA Bruggeman","year":"2000","unstructured":"Bruggeman LA  et al. (2000) Renal epithelium is a previously unrecognized site of HIV-1 infection. J Am Soc Nephrol 11: 2079\u20132087","journal-title":"J Am Soc Nephrol"},{"key":"BFncpneph0166_CR56","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1681\/ASN.V10151","volume":"10","author":"L Barisoni","year":"1999","unstructured":"Barisoni L  et al. (1999) The dysregulated podocyte phenotype: a novel concept in the pathogenesis of collapsing idiopathic focal segmental glomerulosclerosis and HIV-associated nephropathy. J Am Soc Nephrol 10: 51\u201361","journal-title":"J Am Soc Nephrol"},{"key":"BFncpneph0166_CR57","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1046\/j.1523-1755.2000.00280.x","volume":"58","author":"JA Eustace","year":"2000","unstructured":"Eustace JA  et al. (2000) Cohort study of the treatment of severe HIV-associated nephropathy with corticosteroids. Kidney Int 58: 1253\u20131260","journal-title":"Kidney Int"},{"key":"BFncpneph0166_CR58","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1056\/NEJM199209033271006","volume":"327","author":"PL Kimmel","year":"1992","unstructured":"Kimmel PL  et al. (1992) Brief report: idiotypic IgA nephropathy in patients with human immunodeficiency virus infection. N Engl J Med 327: 702\u2013706","journal-title":"N Engl J Med"},{"issue":"Suppl 35","key":"BFncpneph0166_CR59","first-page":"S72","volume":"40","author":"TM Cosgriff","year":"1991","unstructured":"Cosgriff TM and Lewis RM (1991) Mechanism of disease in hemorragic fever with renal syndrome. Kidney Int 40 (Suppl 35): S72\u2013S79","journal-title":"Kidney Int"},{"key":"BFncpneph0166_CR60","first-page":"197","volume":"34","author":"L Grcevska","year":"1990","unstructured":"Grcevska L  et al. (1990) Different pathohistological presentations of acute renal involvement in Hantan virus infection: report of two cases. Clin Nephrol 34: 197\u2013201","journal-title":"Clin Nephrol"},{"key":"BFncpneph0166_CR61","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1111\/j.1523-1755.2005.67130.x","volume":"67","author":"KH Chu","year":"2005","unstructured":"Chu KH  et al. (2005) Acute renal impairment in coronavirus-associated severe acute respiratory syndrome. Kidney Int 67: 698\u2013705","journal-title":"Kidney Int"},{"key":"BFncpneph0166_CR62","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1093\/ndt\/15.3.324","volume":"15","author":"V Nickeleit","year":"2000","unstructured":"Nickeleit V  et al. (2000) BK-virus nephropathy in renal transplants\u2014tubular necrosis, MHC-class II expression and rejection in a puzzling game. Nephrol Dial Transplant 15: 324\u2013332","journal-title":"Nephrol Dial Transplant"},{"key":"BFncpneph0166_CR63","doi-asserted-by":"crossref","first-page":"807","DOI":"10.5858\/1999-123-0807-BVRIIA","volume":"123","author":"M Nebuloni","year":"1999","unstructured":"Nebuloni M  et al. (1999) BK virus renal infection in a patient with the acquired immunodeficiency syndrome. Arch Pathol Lab Med 123: 807\u2013811","journal-title":"Arch Pathol Lab Med"},{"key":"BFncpneph0166_CR64","doi-asserted-by":"publisher","first-page":"138","DOI":"10.5414\/CNP62138","volume":"62","author":"SR Cheema","year":"2004","unstructured":"Cheema SR  et al. (2004) IgA-dominant glomerulonephritis associated with hepatitis A. Clin Nephrol 62: 138\u2013143","journal-title":"Clin Nephrol"},{"key":"BFncpneph0166_CR65","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1136\/bmj.2.6133.338","volume":"2","author":"SP Wilkinson","year":"1978","unstructured":"Wilkinson SP  et al. (1978) Renal failure in otherwise uncomplicated acute viral hepatitis. Br Med J 2: 338\u2013341","journal-title":"Br Med J"},{"key":"BFncpneph0166_CR66","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s00467-003-1152-y","volume":"18","author":"JD Tsai","year":"2003","unstructured":"Tsai JD  et al. (2003) Epstein\u2013Barr virus-associated acute renal failure: diagnosis, treatment, and follow-up. Pediatr Nephrol 18: 667\u2013674","journal-title":"Pediatr Nephrol"},{"key":"BFncpneph0166_CR67","doi-asserted-by":"publisher","first-page":"221","DOI":"10.4269\/ajtmh.2005.72.221","volume":"72","author":"IK Lee","year":"2005","unstructured":"Lee IK  et al. (2005) Clinical characteristics and risk factors for concurrent bacteremia in adults with dengue hemorrhagic fever. Am J Trop Med Hyg 72: 221\u2013226","journal-title":"Am J Trop Med Hyg"}],"container-title":["Nature Clinical Practice Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/ncpneph0166.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ncpneph0166","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ncpneph0166.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T10:25:01Z","timestamp":1744367101000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncpneph0166"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5,1]]},"references-count":67,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,5,1]]}},"alternative-id":["BFncpneph0166"],"URL":"https:\/\/doi.org\/10.1038\/ncpneph0166","relation":{},"ISSN":["1745-8323","1745-8331"],"issn-type":[{"value":"1745-8323","type":"print"},{"value":"1745-8331","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,5,1]]},"assertion":[{"value":"28 October 2005","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2006","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}